Ferrán Navarro
Impact in
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria
- Endocrinology top 0.2%
- Enterobacteriaceae and Cronobacter Research
- Escherichia coli research studies
Papers in
-
- Antibiotic Resistance in Bacteria 82
-
- Enterobacteriaceae and Cronobacter Research 12
- Co-authors
- Elisenda MiróBeatriz MirelisPere CollMaite MuniesaGuillem PratsAntonio OliverPatrice CourvalinAlba Rivera
- Journals
- Antimicrobial Agents and Chemotherapy (18 papers)Journal of Antimicrobial Chemotherapy (13 papers)European Journal of Clinical Microbiology & Infectious Diseases (6 papers)Clinical Microbiology and Infection (6 papers)International Journal of Antimicrobial Agents (5 papers)
- Partner nations
- SpainFranceUnited Kingdom
In The Last Decade
Ferrán Navarro
142 papers receiving 4.6k citations
Peers
Comparison fields: 5 of 125
- Molecular Medicine 2.9k
- Endocrinology 1.5k
- Applied Microbiology and Biotechnology 303
- Pollution 868
- Clinical Biochemistry 477
Countries citing papers authored by Ferrán Navarro
This map shows the geographic impact of Ferrán Navarro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferrán Navarro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferrán Navarro more than expected).
Fields of papers citing papers by Ferrán Navarro
This network shows the impact of papers produced by Ferrán Navarro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferrán Navarro. The network helps show where Ferrán Navarro may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ferrán Navarro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 25 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 7 | |
| 7 | 2022 | 5 | |
| 8 | 2020 | 26 | |
| 9 | 2020 | 10 | |
| 10 | 2020 | 9 | |
| 11 | 2020 | 27 | |
| 12 | 2020 | 14 | |
| 13 | 2020 | 8 | |
| 14 | 2018 | 18 | |
| 15 | 2016 | 10 | |
| 16 | 2016 | 58 | |
| 17 | In Vitro Activity of Ceftazidime and Meropenem in Combination with Tobramycin or Ciprofloxacin in A Clone of Multiresistant Pseudomonas Aeruginosa | 2013 | 1 |
| 18 | 2010 | 49 | |
| 19 | 2007 | 13 | |
| 20 | 2004 | 19 |
About Ferrán Navarro
Ferrán Navarro is a scholar working on Molecular Medicine, Endocrinology, Applied Microbiology and Biotechnology, Pollution and Infectious Diseases, having authored 147 papers that have together received 4.8k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (82 papers), Antibiotics Pharmacokinetics and Efficacy (28 papers), Pharmaceutical and Antibiotic Environmental Impacts (23 papers), Bacteriophages and microbial interactions (22 papers), Salmonella and Campylobacter epidemiology (19 papers), Pneumonia and Respiratory Infections (17 papers), Enterobacteriaceae and Cronobacter Research (12 papers) and Bacterial Identification and Susceptibility Testing (12 papers). The work is most often cited by research in Molecular Medicine (2.9k citations), Endocrinology (1.5k citations), Applied Microbiology and Biotechnology (303 citations), Pollution (868 citations) and Clinical Biochemistry (477 citations). Ferrán Navarro has collaborated with scholars based in Spain, France and United Kingdom. Frequent co-authors include Elisenda Miró, Beatriz Mirelis, Pere Coll, Maite Muniesa, Guillem Prats, Antonio Oliver, Patrice Courvalin, Alba Rivera, G Prats and Jesús Oteo. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases, Clinical Microbiology and Infection and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.